Neuroinflammatory Pathways in Autism Spectrum Disorder: Unraveling the Role of Sirtuin 1 in Clinical Samples.

Researchers measured certain proteins in the blood of 46 autistic children and 44 non-autistic children to see if inflammation might be linked to autism. They found no differences in these inflammation markers between autistic and non-autistic children. The proteins were connected to each other in expected ways, and older children had higher levels. This study doesn't support the idea that blood inflammation markers are different in autism.

This study investigated the relationship between Sirtuin 1 (SIRT1) and inflammatory markers IL-6 and TNF-α in 46 children with autism spectrum disorder compared to 44 typically developing children aged 36-120 months. Contrary to hypotheses, no significant differences were found in serum levels of SIRT1, IL-6, or TNF-α between groups. However, strong positive correlations were observed between SIRT1 and both inflammatory markers within participants. Regression behaviors showed negative correlations with inflammatory markers, and age was positively correlated with all measured biomarkers.

The findings do not support the role of circulating cytokines and SIRT1 as indicators of systemic inflammation in autism, suggesting the neuroinflammatory hypothesis may need refinement.

Results suggest that serum inflammatory markers and SIRT1 may not serve as reliable biomarkers for autism diagnosis or monitoring. Clinicians should not rely on these blood markers for autism assessment. The study highlights the need for more comprehensive approaches to understanding neuroinflammation in autism.

Small sample size (90 total participants), cross-sectional design preventing causal inferences, single biomarker measurement timepoint, and lack of longitudinal follow-up. Authors specifically recommend larger sample sizes and longitudinal studies for future research.

Despite extensive research, the etiological factors contributing to autism spectrum disorder (ASD) remain incompletely understood, with potential influences ranging from genetic predispositions to environmental factors. Sirtuin 1 (SIRT1), an NAD-dependent histone deacetylase involved in mitigating oxidative stress and its association with other neurodevelopmental disorders, explores its function in ASD. This study aimed to elucidate the relationship between SIRT1 and inflammatory cytokines, specifically interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), in patients with ASD. This study enrolled 46 children diagnosed with ASD and 44 typically developing (TD) children aged 36-120 months.

Diagnosis of ASD was confirmed using DSM-5 criteria through clinical and observational assessments conducted by three experienced child and adolescent psychiatrists at the outpatient Infant Mental Health unit of Ankara University. The Childhood Autism Rating Scale (CARS) and the Repetitive Behavior Scale-Revised (RBS-R) were used to assess autistic behaviors. Analysis of serum levels of SIRT1, IL-6, and TNF-α revealed no significant differences between the ASD group and the TD group. Correlation analysis demonstrated a significant positive relationship between SIRT1 levels and IL-6 (r = 0.71, p < 0.001) and TNF-α (r = 0.86, p < 0.001).

Additionally, regression phenomena exhibited a moderate negative correlation with IL-6 (r = -0.32, p = 0.02) and TNF-α (r = -0.38, p = 0.008). Age was positively correlated with levels of IL-6, TNF-α, and SIRT1. However, no correlations were found between these parameters and gender. These findings do not support the hypothesized role of disturbances in the expression of circulating cytokines and SIRT1 as indicators of systemic inflammation in autism.

Further longitudinal studies should examine these immune markers in blood samples from large sample sizes.